Orofer FCM 1K Injection

Introduction of Orofer FCM 1K Injection

Orofer FCM 1K Injection is an iron replacement medicine containing Ferric Carboxymaltose 50 mg/mL. The 1K strength contains 1000 mg of iron in a 20 mL vial. It is an intravenous iron preparation used to replenish iron stores and treat iron-deficiency anaemia, particularly when oral iron treatment is not effective, not tolerated, or intravenous iron is considered appropriate by the treating doctor.

Iron is an essential mineral required for the production of haemoglobin and red blood cells. By supplying iron directly into the bloodstream, Ferric Carboxymaltose helps restore iron levels and supports normal haemoglobin production.

Uses of Orofer FCM 1K Injection

Orofer FCM 1K Injection may be prescribed for:

• Treatment of iron-deficiency anaemia
• Replenishment of depleted iron stores
• Iron deficiency when oral iron supplements are ineffective or poorly tolerated
• Iron deficiency associated with certain chronic medical conditions
• Patients requiring intravenous iron replacement as determined by a healthcare professional

The exact indication and required amount of iron should be determined from the patient’s clinical condition and laboratory investigations.

How to Use Orofer FCM 1K Injection

Orofer FCM 1K Injection is administered into a vein (intravenously) by a doctor, nurse, or other qualified healthcare professional. It may be given as a slow intravenous injection or infusion according to the prescribed treatment protocol.

The dose is not the same for every patient. It may depend on factors such as body weight, haemoglobin level, iron deficiency and overall medical condition. Do not attempt to inject this medicine yourself and do not take an additional dose without medical advice.

Patients should generally be observed during and after administration because allergic or hypersensitivity reactions can occur.

Side Effects of Orofer FCM 1K Injection

Some patients may experience side effects such as:

• Nausea
• Headache
• Dizziness
• Flushing
• Temporary increase in blood pressure
• Injection-site pain, redness or irritation
• Skin rash
• Low phosphate levels in the blood (hypophosphataemia)

Most side effects may be temporary, but patients should inform their healthcare provider if symptoms are severe, persistent or unusual.

Rarely, serious hypersensitivity or allergic reactions can occur. Symptoms such as difficulty breathing, swelling, severe dizziness, fainting or sudden low blood pressure require immediate medical attention.

Safety Advice

• Use only on a doctor’s prescription: Orofer FCM 1K Injection should be administered under medical supervision.
• Do not self-inject: This medicine is intended for intravenous administration by a qualified healthcare professional.
• Allergy information: Tell your doctor if you have previously experienced an allergic reaction to Ferric Carboxymaltose or any intravenous iron preparation.
• Pregnancy and breastfeeding: Inform your doctor if you are pregnant, planning pregnancy or breastfeeding before receiving treatment.
• Medical conditions: Inform your doctor about kidney problems, liver problems, allergies and other existing medical conditions.
• Blood tests: Your doctor may monitor haemoglobin, iron levels and other relevant blood parameters during treatment.
• Phosphate monitoring: Patients receiving repeated courses or those at risk of low phosphate may require monitoring of serum phosphate levels.
• During administration: Tell the healthcare professional immediately if you experience breathing difficulty, rash, swelling, dizziness or feeling faint.
• Storage: Store the injection according to the conditions specified on the product packaging and keep it out of reach of children.

Important: Orofer FCM 1K Injection should be used strictly according to the advice of a qualified healthcare professional. This product description is for educational and informational purposes and should not replace professional medical advice.